Innovation with Glycans: New Frontiers from Synthesis to New Biological Targets (ex COST action)

Joined April 2019
On the importance of dissemination and communication is Science. Glycans and Glycosciences: an intro for everyone innogly.eu/glycans-and-glyco… #glycotime
2
47
8
87
13,854
New online! Reverse vaccinology 3.0 dlvr.it/TRR35t
1
21
2
65
5,736
INNOGLY COST Action retweeted
Very proud of @Kwon_Dongil, @sachinbhag, and Stephen Ehrenzeller for putting together a new review - "Harnessing mucosal immunity for protective vaccines" published today @NatRevImmunol! Please use the link below to access this review 📖 rdcu.be/e4eEU
3
63
5
199
25,926
INNOGLY COST Action retweeted
5 clinical trials to watch in 2026 Ras inhibition in pancreatic cancer, new approaches for prevention of heart disease, Retatrutide vs. Tirzepatide for obesity, and a next-generation antibody in Alzheimer's disease Read it here: breakingground.substack.com/…
8
71
3
329
63,299
INNOGLY COST Action retweeted
10 breakthroughs in medicine in 2025 Read it here: breakingground.substack.com/…
33
304
22
1,026
263,731
INNOGLY COST Action retweeted
Discovery of a new checkpoint of cancer cells, a pathway to block and enhance immunotherapy cell.com/cell-reports/fullte…
4
87
2
357
25,837
INNOGLY COST Action retweeted
Download our large database of funding opportunities for early-career faculty and researchers Download it here: research.jhu.edu/rdt/funding… 433 funding opportunities.
2
181
4
773
75,999
INNOGLY COST Action retweeted
Protein glycosylation: an emerging regulator of allergic diseases tinyurl.com/bdw7j958 #gtlycotime
3
7
314
INNOGLY COST Action retweeted
Just in case any one is wondering: Biomedical scientists spend an average of 12 years in training before reaching an independent position. That is more than most medical residences.
48
107
9
613
37,451
INNOGLY COST Action retweeted
Sugar coats shield immunogenic RNA modification: A new function for RNA glycosylation: Molecular Cell cell.com/molecular-cell/full… @VinnieViruses
5
15
896
INNOGLY COST Action retweeted
Finally, someone has solved a real problem with AI! No more having to take a paper in the format for a journal that rejected you, and reformat it for a new journal. Well done!! formatmypaper.com/
45
427
77
2,512
257,571
INNOGLY COST Action retweeted
meta-PAMPs: A new class of immunostimulatory molecules that control the ability of bacterial factors to operate as PAMPs. Jordan Jastrab reveals that wall teichoic acid (WTA) is a key regulator of inflammasomes and interferons during infection. biorxiv.org/content/10.1101/…
5
11
53
3,791
INNOGLY COST Action retweeted
bioRxiv has a dedicated section for negative results. Use it. Share negative results. Your colleagues will appreciate it.
19
385
30
1,909
187,226
INNOGLY COST Action retweeted
Lessons from neoadjuvant immunotherapy in melanoma: understanding antitumour immunity and tumour escape bit.ly/3KbHowV
36
1
100
7,789